SKIN Angels Podcast
In this episode of the SKIN Angels Podcast, I sit down with Oliver Liu, co-founder and CEO of Topaz Biosciences and the Hypothesis brand, to explore one of the most exciting frontiers in dermatology: precision engineering of the skin microbiome. Oliver shares how his background in metagenomics, synthetic biology, and microbiome research led to the development of highly targeted enzymes designed to selectively remove problematic bacteria while preserving the beneficial microbes that support healthy skin. We discuss the science behind microbiome-directed skincare, the challenges of building a biotechnology company from the ground up, the realities of product development and formulation, and why precision approaches may ultimately replace many of the broad-spectrum treatments that have dominated dermatology for decades. This was a fascinating conversation about innovation, perseverance, scientific discovery, and the future of precision skin health. More at: https://hypothesis.bio/ [https://hypothesis.bio/]
9 episodes
Comments
0Be the first to comment
Sign up now and become a member of the SKIN Angels Podcast community!